ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,752Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 1000

$865K Total Retail Price of All Prescriptions

Rank: 87 out of 1000

513 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 513 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 513 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 13,282 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
METFORMIN HCL 505 427 1 8
FUROSEMIDE 440 351 2 7
SIMVASTATIN 432 368 3 3
OMEPRAZOLE 424 308 4 2
AMLODIPINE BESYLATE 420 364 5 6
HYDROCODONE-ACETAMINOPHEN 405 365 S3 6 1
LISINOPRIL 356 307 7 5
SPIRONOLACTONE 349 294 8 78
LEVOTHYROXINE SODIUM 314 259 9 4
CARVEDILOL 292 272 10 15
POTASSIUM CHLORIDE 292 225 10 10
PRAVASTATIN SODIUM 284 230 12 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 284 258 12 20
METOPROLOL TARTRATE 267 242 14 19
HYDROCHLOROTHIAZIDE 260 211 15 9
ALLOPURINOL 254 214 16 31
TRAMADOL HCL 236 199 17 13
WARFARIN SODIUM 225 222 18 22
METOPROLOL SUCCINATE 212 175 19 21
GABAPENTIN 209 180 20 11
EVISTA 183 183 21 168
NEXIUM 150 136 22 23
DIGOXIN 148 147 23 52
ZOLPIDEM TARTRATE 146 142 24 16
LOSARTAN POTASSIUM 142 129 25 25
ZETIA 136 136 26 95
CLOPIDOGREL 136 128 26 35
CLONIDINE HCL 134 102 28 27
NAMENDA 127 125 29 43
CITALOPRAM HBR 127 110 29 17
ATENOLOL 126 121 31 24
LOSARTAN-HYDROCHLOROTHIAZIDE 125 109 32 38
INSULIN SYRINGE 121 87 33 93
DONEPEZIL HCL 120 119 34 32
MECLIZINE HCL 120 101 34 80
GLIMEPIRIDE 110 101 36 34
DILTIAZEM 24HR ER 105 96 37 189
ADVAIR DISKUS 105 96 37 65
CIPROFLOXACIN HCL 105 78 37 46
PAROXETINE HCL 102 85 40 63
LYRICA 102 81 40 47
DIOVAN HCT 101 87 42 96
LANTUS 100 72 43 68
POLYETHYLENE GLYCOL 3350 99 85 44 69
HUMULIN 70-30 96 65 45 131
CYCLOBENZAPRINE HCL 94 43 R 46 39
PLAVIX 93 85 47 49
ACTOS 91 75 48 119
DOXEPIN HCL 90 84 49 176
PREDNISONE 86 75 50 42
NOVOLIN 70-30 86 75 50 160
DILTIAZEM 24HR CD 85 77 52 136
MELOXICAM 85 68 52 14
KLOR-CON 10 82 52 54 104
TAMSULOSIN HCL 80 80 55 33
ATORVASTATIN CALCIUM 79 76 56 18
TRIAMTERENE-HCTZ 78 56 57 48
SINGULAIR 78 55 57 84
ACETAMINOPHEN-CODEINE 77 48 S3 59 127
PREMARIN 76 45 R 60 109
JANUVIA 76 63 60 85
NAPROXEN 71 48 62 81
SYNTHROID 70 67 63 91
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 53 64 70
METHYLPREDNISOLONE 68 61 64 103
EXELON 67 67 66 108
NITROFURANTOIN 65 54 67 199
GLYBURIDE-METFORMIN HCL 64 52 R 68 121
FLUTICASONE PROPIONATE 62 54 69 40
CAPTOPRIL 61 55 70 260
AMLODIPINE BESYLATE-BENAZEPRIL 61 61 70 59
CELEBREX 61 61 70 98
MONTELUKAST SODIUM 61 47 70 132
MUPIROCIN 61 36 70 140
TOPIRAMATE 60 31 75 181
PROMETHAZINE HCL 57 33 R 76 54
VERAPAMIL ER 57 54 76 86
PROPRANOLOL HCL 56 37 78 135
FINASTERIDE 56 56 78 177
RESTASIS 55 55 80 272
AZITHROMYCIN 53 44 81 36
CYMBALTA 52 29 82 53
PANTOPRAZOLE SODIUM 52 40 82 28
SERTRALINE HCL 50 39 84 26
ALENDRONATE SODIUM 50 50 84 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.